Vivo Capital’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,546,485
| Closed | -$95.8M | – | 49 |
|
|
2023
Q4 | $95.8M | Sell |
9,546,485
-1,334,659
| -12% | -$13.4M | 7.85% | 2 |
|
|
2023
Q3 | $31.3M | Buy |
10,881,144
+6,911,717
| +174% | +$19.9M | 3.43% | 10 |
|
|
2023
Q2 | $15.1M | Buy |
3,969,427
+2,505,444
| +171% | +$9.55M | 1.04% | 14 |
|
|
2023
Q1 | $2.72M | Buy |
1,463,983
+502,625
| +52% | +$935K | 0.19% | 39 |
|
|
2022
Q4 | $2.21M | Sell |
961,358
-1
| -0% | -$2 | 0.25% | 41 |
|
|
2022
Q3 | $3.1M | Hold |
961,359
| – | – | 0.34% | 43 |
|
|
2022
Q2 | $5.29M | Hold |
961,359
| – | – | 0.53% | 36 |
|
|
2022
Q1 | $2.24M | Hold |
961,359
| – | – | 0.15% | 49 |
|
|
2021
Q4 | $5.81M | Hold |
961,359
| – | – | 0.35% | 44 |
|
|
2021
Q3 | $13.3M | Sell |
961,359
-366,898
| -28% | -$5.09M | 0.6% | 31 |
|
|
2021
Q2 | $17.3M | Sell |
1,328,257
-194,737
| -13% | -$2.53M | 0.75% | 28 |
|
|
2021
Q1 | $23.5M | Buy |
+1,522,994
| New | +$23.5M | 0.82% | 26 |
|